Top ▲
Quaternary Structure: Subunits |
Oncostatin M-specific receptor, β subunit (Ligand-binding subunit) |
Interleukin-6 receptor, β subunit (Other subunit) |
Natural/Endogenous Ligands |
oncostatin M {Sp: Human} |
Download all structure-activity data for this target as a CSV file
Agonists | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
The oncostatin M receptor (from the OSMR gene) is a type I cytokine receptor. This protein heterodimerizes with the interleukin 6 signal transducer (IL6ST) to form the type II oncostatin M receptor, or with the interleukin 31 receptor α subunit (IL31RA) to form the IL-31 receptor. Germline mutations in OSMR underlie familial primary localized cutaneous amyloidosis [1], a finding that provides further understanding of the roles of oncostatin M and IL-31 in itch pathology. |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||||||
|
1. Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR et al.. (2008) Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet, 82 (1): 73-80. [PMID:18179886]
2. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. (2009) New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol, 161 (6): 1217-24. [PMID:19663869]
IL-6 receptor family: Oncostatin-M receptor. Last modified on 15/07/2024. Accessed on 08/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2315.